Graves Ophthalmopathy Recruiting Phase 3 Trials for Simvastatin (DB00641)

Also known as: Graves ophthalmopathy / Ophthalmopathy, Graves / Thyroid eye disease / Graves' ophthalmopathy / Endocrine ophthalmopathy

IndicationStatusPhase
DBCOND0000969 (Graves Ophthalmopathy)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03131726Treatment of Graves┬┤Ophthalmopathy With Simvastatin (GO-DS)Treatment